Aristotle University Of Thessaloniki (AUTH)
Engineering optimal culture conditions to trans-differentiate dermal fibroblasts towards tenogenic lineage
Abstract
dc:descriptionRegenerative medicine, employing cells, biomaterials, biologically active substances, and combinations thereof as therapeutic agents, appears as a promising solution for the treatment of a wide range of medical conditions. Although their clinical use is currently limited to skin repair and regeneration procedures, dermal fibroblasts possess a unique set of biological characteristics that make them a very attractive cell population for broader regenerative applications. Consequently, dermal fibroblasts have recently been investigated for the regeneration of several tissues and organs, including the components of the musculoskeletal system. Nearly half of the musculoskeletal injuries reported annually involve tendon or ligament tissues. Although tendon tissue grafts are used extensively in the clinic, their low availability, donor-site morbidity, immune rejection, and disease transmission currently unbalance their therapeutic benefits. Several cell types, including dermal fibroblasts, have been explored for the development of tissue-engineered substitutes for tendon and ligament repair. However, the prolonged in vitro culture required to develop an implantable device, associated cost of goods, loss of native tenocyte phenotype, and lack of robust differentiation procedures currently hinder the clinical realisation of tendon tissue-engineered products. Considering that macromolecular crowding technology has the potential to substantially accelerate the development of functional tissue facsimiles, herein an in-depth analysis of human tenocyte and dermal fibroblast cultures under standard and macromolecular crowding conditions was conducted. The obtained results demonstrated high similarities between human tenocytes and dermal fibroblasts under both experimental conditions, highlighting the potential of the combination of dermal fibroblasts with macromolecular crowding for tendon tissue engineering. It was also found that macromolecular crowding not only increases and accelerates extracellular matrix deposition but also enhances haemostatic, anti-microbial, and tissue-protective activities, further de-risking macromolecular crowding technology for the accelerated development of advanced therapy medicinal products. In addition, during this study, it was detected that human tenocytes produced higher amounts of TGFB2 than dermal fibroblasts, highlighting this growth factor as a potential tool to shift the dermal fibroblast phenotype towards the tenogenic lineage. Subsequently, given the prominent role of tissue-specific microenvironments in cell fate determination and the complexity of the microenvironment to which tendon resident cells are subjected in vivo, a tendon-mimicking microenvironment was engineered in vitro by employing an anisotropic biomaterial substrate, TGFB2, and macromolecular crowding in a multifactorial approach. The potential of the engineered tendon microenvironment was evaluated for the redifferentiation of human tenocytes and the transdifferentiation of dermal fibroblasts towards the tenogenic lineage. The obtained results demonstrated the value of the selected microenvironmental cues to emulate tenogenic traits, thereby facilitating the development of an in vitro microenvironment simulating native tendon characteristics, capable of redifferentiating human tenocytes and transdifferentiating dermal fibroblasts towards the tenogenic lineage. Furthermore, this approach led to the generation of tissue-engineered constructs featuring tenogenic cells arranged in a parallel manner, embedded within a dense tendon-specific extracellular matrix, possessing an anisotropic structure. Taking into account their features, these structures could be useful not only for creating innovative tendon treatments, but also for developing tendon microphysiological systems with significance in fundamental research, disease modelling, and drug discovery.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Djalali-Cuevas, Adrian-Amadeo
- Τζαλάλι-Κουέβας, Άντριαν-Αμαντέο
Subjects
dc:subject × 20- Τένοντας
- Δερματικοί ινοβλάστες
- Μηχανική ιστών
- Αναγεννητική ιατρική
- Tendon
- Dermal fibroblasts
- Tissue engineering
- Regenerative medicine
- Βιολογία
- Φυσικές Επιστήμες
- Βιολογία κυττάρου
- Βιοχημεία και Μοριακή βιολογία
- Ιατρική Βιοτεχνολογία
- Ιατρική και Επιστήμες Υγείας
- Biological Sciences
- Natural Sciences
- Cell Biology
- Biochemistry and Molecular Biology
- Medical Biotechnology
- Medical and Health Sciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57775